Focus on titanium, but does not tell if it´s about EBM.
Good chance it will benefit Arcam anyway. As CEO René told us in the latest interview regarding the AP&C expansions.
“And remember at AP&C our capacity, we own more than 50% of the titanium powder market for additive. Maybe we own 70% of the market.”
"But AP&C’s fortunes are not intrinsically tied to the adoption of EBM. “Actually we sell as much powder to laser [powder bed fusion] machine users as we do to EBM machine users. Roughly half of the powder we make at AP&C goes into laser machines.”"